Healthcare -
Biotechnology - NASDAQ - US
$ 10.14
-2.12 %
$ 764 M
Market Cap
-3.34
P/E
REPL - TOTAL LIABILITIES
Total Liabilities REPL - Replimune Group, Inc.
113 M
LAST VALUE
50.53%
2 YEAR CAGR
47.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR